About HistoGenetics
HistoGenetics is a company based in Ossining (United States) founded in 2006 by NEZIH CEREB. It operates as a B2B. The company has 42 employees as of March 31, 2023. HistoGenetics offers products and services including HLA Typing Service, Genomic Sequencing, Pharmacogenomics Testing, and ABO Rh Typing. HistoGenetics operates in a competitive market with competitors including Omniome, HitGen, Rejuvenate Bio, Novogene Corporation and NovellusDx, among others.
- Headquarter Ossining, United States
- Employees 42 as on 31 Mar, 2023
- Founders NEZIH CEREB
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Histogenetics (India) Private Limited
- Date of Incorporation 18 Dec, 2006
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$1.03 M (USD)3.18as on Mar 31, 2023
-
Net Profit
$123.7 K (USD)27.71as on Mar 31, 2023
-
EBITDA
$174.53 K (USD)33.99as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
42
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HistoGenetics
HistoGenetics offers a comprehensive portfolio of products and services, including HLA Typing Service, Genomic Sequencing, Pharmacogenomics Testing, and ABO Rh Typing.
High-resolution sequencing for HLA genes in transplantation and research.
Whole genome analysis using PacBio for health and disease studies.
Testing for drug response variants like FCGR genes.
Predicts blood types through NGS for registry purposes.
People of HistoGenetics
Unlock access to complete
Unlock access to complete
Funding Insights of HistoGenetics
Detailed funding history for HistoGenetics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HistoGenetics
Investment portfolio details for HistoGenetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HistoGenetics
Detailed financials for HistoGenetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Histogenetics Comparisons
Peer comparison for HistoGenetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HistoGenetics
HistoGenetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, HitGen, Rejuvenate Bio, Novogene Corporation and NovellusDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Developer of technology for precision cancer diagnosis and therapies
|
|
| Locked | Locked | Locked |
Meta-genomics platforms and services for microbiome studies are provided.
|
Detailed competitors of HistoGenetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Histogenetics
Complete news archive for HistoGenetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HistoGenetics
HistoGenetics was founded in 2006.
HistoGenetics is headquartered in Ossining, United States. It is registered at Ossining, New York, United States.
NEZIH CEREB is the current CEO of HistoGenetics. They have also founded this company.
As of Mar 31, 2023, the latest employee count at HistoGenetics is 42.
Annual revenue of HistoGenetics is $1.03M as on Mar 31, 2023.
HistoGenetics specializes in advanced HLA sequence-based typing and genomic services using technologies like PacBio and Illumina. They provide cost-effective testing for donor registries, transplant centers, and laboratories, focusing on immunogenetics and pharmacogenomics. Based in Ossining, NY, USA, they ensure high-quality assurance and fast turnaround for precision medicine applications, including whole genome sequencing and allele-level analysis.
HistoGenetics's top competitors include Novogene Corporation, BGI and Omniome.
HistoGenetics offers HLA Typing Service, Genomic Sequencing, Pharmacogenomics Testing, and ABO Rh Typing.